Is Curaleaf Stock a Buy With Its Attempted Hostile Takeover of Aurora Cannabis Under Way?

Curaleaf formally launched a hostile takeover bid for Aurora Cannabis on August 18, 2026, offering $4 per share (45% premium) with potential to reach $5 per share. The analyst recommends passing on Curaleaf stock, citing regulatory mismatches between U.S. and Canadian markets, complicated international distribution networks, and neither company's proven profitability track record. Aurora shares trade at a discount to the offer price, suggesting investor skepticism about deal completion.